Privo Technologies Launches BeneVet Oncology: Advancing Comp
24 Mar 2025 //
PR NEWSWIRE
Privo Appoints Dr. Albert Collinson as Independent Non-Executive Director
09 Nov 2023 //
PR NEWSWIRE
Privo Technologies Receives U.S. FDA Orphan Drug Designation
12 Aug 2022 //
PRNEWSWIRE